Page last updated: 2024-10-26

valproic acid and Agoraphobia

valproic acid has been researched along with Agoraphobia in 4 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Agoraphobia: Obsessive, persistent, intense fear of open places.

Research Excerpts

ExcerptRelevanceReference
"Sodium valproate (VA) and clonazepam (CLZ) were combined in the treatment of 4 patients with panic disorders (PD) who were resistant to several antipanic drug treatments."7.68Sodium valproate and clonazepam for treatment-resistant panic disorder. ( Fontaine, R; Ontiveros, A, 1992)
"Sodium valproate (VA) and clonazepam (CLZ) were combined in the treatment of 4 patients with panic disorders (PD) who were resistant to several antipanic drug treatments."3.68Sodium valproate and clonazepam for treatment-resistant panic disorder. ( Fontaine, R; Ontiveros, A, 1992)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Esposito, M1
Giunta, A1
Del Duca, E1
Manfreda, V1
Troisi, A1
Bianchi, L1
Fargnoli, MC1
Baetz, M1
Bowen, RC1
Ontiveros, A1
Fontaine, R1
McElroy, SL1
Keck, PE1
Lawrence, JM1

Other Studies

4 other studies available for valproic acid and Agoraphobia

ArticleYear
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series.
    Postgraduate medicine, 2020, Volume: 132, Issue:2

    Topics: Adult; Agoraphobia; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Antimanic Agents; Benz

2020
Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998, Volume: 43, Issue:1

    Topics: Adolescent; Adult; Affect; Aged; Agoraphobia; Anxiety Disorders; Bipolar Disorder; Cognitive Behavio

1998
Sodium valproate and clonazepam for treatment-resistant panic disorder.
    Journal of psychiatry & neuroscience : JPN, 1992, Volume: 17, Issue:2

    Topics: Adult; Agoraphobia; Clonazepam; Drug Synergism; Drug Therapy, Combination; Female; gamma-Aminobutyri

1992
Treatment of panic disorder and benzodiazepine withdrawal with valproate.
    The Journal of neuropsychiatry and clinical neurosciences, 1991,Spring, Volume: 3, Issue:2

    Topics: Adult; Agoraphobia; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Humans; Male; Panic Diso

1991